Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes


Transcriptional profiling in hiPSC-CMs treated with COVID-19 drugs identified unfavorable changes with lopinavir/ritonavir and lopinavir/ritonavir/INF-β in key cardiac gene programs that may negatively affect heart function. Copyright © 2022 Jakobi, Groß, Cyganek and Doroudgar.

Authors Jakobi T, Groß J, Cyganek L, Doroudgar S
Journal Frontiers in cardiovascular medicine
Publication Date 2022;9:844441
PubMed 35686037
PubMed Central PMC9170897
DOI 10.3389/fcvm.2022.844441

Research Projects

Cell Lines